Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01306799 · ClinicalTrials.gov registry record
To Learn How Bone Structure and Bone Mass Change After Long-term PPI Use
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 106
- Enrollment target
NCT01306799: Completed study, sponsored by University of Pennsylvania.
NCT01306799 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 106 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01306799 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 106 participants
- Enrollment target
Study Summary
Patients with severe acid reflux and/or Barrett's esophagus are recommended to take Proton pump inhibitors (PPIs)indefinitely to prevent complications such as strictures or the development of a type of esophageal cancer. Recently, some studies suggested that taking these medications on a long-term basis may affect the bone. Therefore, it is important to learn whether these medications may lead to accelerated bone loss so that effective preventive measures can be developed for patients who require these medications for acid-related conditions. Several studies reported that patients receiving PPIs for many years may have increased risk of hip fractures. However, it is unclear whether this is because the PPIs cause reduced bone density or whether the increased risk of fractures has nothing to do with PPIs and is because patients who require PPIs have other illnesses that cause the increased fractures. The purpose of the study is to learn how bone structure and bone mass change after long-term PPI use.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2010-01 |
| Est. Completion | 2015-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01306799
The ClinicalTrials.gov registry entry for NCT01306799 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01306799 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01306799 about?
NCT01306799 is a clinical study titled "To Learn How Bone Structure and Bone Mass Change After Long-term PPI Use". Patients with severe acid reflux and/or Barrett's esophagus are recommended to take Proton pump inhibitors (PPIs)indefinitely to prevent complications such as strictures or the development of a type of esophageal cancer. Recently, some studies suggested that taking these medications on a long-term b...
What is the current status of trial NCT01306799?
This trial is currently completed. The enrollment target is 106 participants. The study started on 2010-01. Estimated completion is 2015-04.
Who is sponsoring clinical trial NCT01306799?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.